Insulin requires A1 adenosine receptors expression to restore human fetal endothelial function in gestational diabetes

Physiology 2015 (Cardiff, UK) (2015) Proc Physiol Soc 34, C53

Oral Communications: Insulin requires A1 adenosine receptors expression to restore human fetal endothelial function in gestational diabetes

T. Sáez1, R. Salsoso1, L. Silva1, C. Sanhueza1, F. Pardo1, A. Leiva1, L. Sobrevia1,2

1. Obstetrics and Gynaecology, Pontificia Universidad Catolica de Chile, Santiago, Chile. 2. UQCCR, University of Queensland, Queensland, Queensland, Australia.

View other abstracts by:


Reduced adenosine uptake via human equilibrative nucleoside transporters 1 (hENT1) in human umbilical vein endothelial cells (HUVECs) from gestational diabetes (GD) is reversed by insulin by restoring hENT1 expression (Westermeier et al. 2015). In addition, GD-increased L-arginine transport via the human cationic amino acid transporter 1 (hCAT-1) is modulated by insulin in this cell type (Guzmán-Gutiérrez et al. 2012). Insulin modulation of L-arginine transport idepends on expression and activation of A2A adenosine receptors (A2AAR) (Guzmán-Gutiérrez et al. 2012). We studied whether the reversal of the associated effects of GD on transport by insulin depends on adenosine receptors expression and activation. hENT1 and hCAT-1 expression (mRNA number of copies, protein abundance) and activity (transport kinetics), and A1AR, A2AAR and IR-A/IR-B expression in primary cultures of HUVECs from normal (n = 68) or GD (n = 68) pregnancies were assayed. Overall adenosine (0.15-500 μM adenosine) and L-arginine (0.75-1000 μM L-arginine) transport was measured in the absence or presence of 1 μM S-(4-nitrobenzyl)-6-thio-inosine (NBTI, ENT1 inhibitor), 2 mM hypoxanthine (ENT2 substrate), or both. Experiments were in A1AR, A2AAR, IR-A, IR-B and IR-A/B knockdown cells in the absence or presence of insulin (0-10 nM, 8 h), CPA (A1AR agonist, 30 nM), DPCPX (A1AR antagonist, 30 nM), CGS-21680 (A2AAR agonist, 30 nM), ZM-241385 (A2AAR antagonist, 10 nM). Values are mean ± SEM (n = 27-31 different cell cultures). Results show that GD associates with higher mRNA and protein abundance of hCAT-1 (1.9 ± 0.3 and 2.2 ± 0.2 fold, respectively) (P<0.03, ANOVA), but reduced mRNA and protein abundance of hENT1 (67 ± 12 and 73 ± 15%, respectively) (P<0.05) compared with normal pregnancies. GD also increased mRNA and protein abundance for A1AR (3.7 ± 1.1 and 4.5 ± 0.8 fold, respectively) and IR-A mRNA (1.7 ± 0.4 fold) (P<0.04). The Vmax for hENT1 adenosine transport was reduced (P<0.02) in GD (2.71 ± 0.12 pmol/μg protein/s) compared with normal (1.01 ± 0.03 pmol/μg protein/s) pregnancies. The Vmax for hCAT-1 L-arginine transport was increased (P<0.03) in GD (3.91 ± 0.41 pmol/μg protein/min) compared with normal (1.29 ± 0.28 pmol/μg protein/min) pregnancies. However, apparent Km values were not significantly (P>0.05) altered. Insulin reversed the GD-associated changes in hENT1 and hCAT-1 expression and activity, and changes in A1AR, A2AAR, and IR-A/IR-B mRNA expression to values in normal pregnancies. However, insulin effects were abolished in A1AR, IR-A or IR-A/B knockdown cells. In conclusion, insulin requires normal A1AR and IR-A expression to restore GD-reduced hENT1 and hCAT-1 expression and activity in HUVECs.



Where applicable, experiments conform with Society ethical requirements.

Site search

Filter

Content Type